1
|
Liang Y, Ren J, Zhong F, Hong W, Su Y, Wu F, Liang S, Liu J, Fang S, Liang Y, Fan X, Lin J, Liu Y, Feng B, Xu Y. Characterization of alternatively spliced transcript variants of glycophorin A and glycophorin B genes in Chinese blood donors. Vox Sang 2022; 117:715-723. [PMID: 35138639 DOI: 10.1111/vox.13252] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/06/2021] [Revised: 11/25/2021] [Accepted: 12/23/2021] [Indexed: 11/28/2022]
Abstract
BACKGROUND AND OBJECTIVES The molecular basis of MNS blood group variants is not fully clear yet. In this study, we have characterized mRNA variants of GYPA and GYPB genes to reveal whether alternative RNA splicing may cause antigenic diversity of the MNS system. MATERIALS AND METHODS Total RNA was extracted from peripheral blood of Chinese blood donors and full-length cDNA products were generated. A nested polymerase chain reaction (PCR)-based method was established for fragment amplification and Sanger sequencing. Resulted full-length mRNA sequences were aligned with GYPA or GYPB genomic sequences respectively for exon identification. Amino acid (AA) sequences of GPA and GPB proteins were extrapolated and GYPA-EGFP, GYPB-EGFP fusion genes were generated to monitor subcellular distribution of the encoded glycophorin (GP) proteins. RESULTS Totally 10 blood samples were analysed. GYPB mRNAs of all the subjects demonstrated frequent exon insertion or deletion whereas this kind of variation was only observed in 3 of 10 GYPA mRNA samples. None of the reported Miltenberger hybrids was detected in any of the mRNA samples. The alternative splicing resulted in changes of AA sequences in N-terminal domains where the MNS antigenic motifs resided; however, subcellular localizations of GP-EGFP fusion proteins showed that the above-mentioned AA changes did not affect cell surface distribution of the encoded GP proteins. CONCLUSIONS Alternative RNA splicing may influence the antigenic features of GP proteins but not their cell surface distribution. Therefore, GYPA and GYPB mRNA characterization might be an invaluable supplement to serological phenotyping and DNA-based genotyping in MNS blood grouping.
Collapse
Affiliation(s)
- Yanlian Liang
- Shenzhen Blood Centre, Shenzhen Institute of Transfusion Medicine, Shenzhen, People's Republic of China
| | - Jianwei Ren
- Centre for Regenerative Medicine and Health, Hong Kong Institute of Science & Innovation, Chinese Academy of Sciences, Hong Kong, People's Republic of China.,R&D Division, Shenzhen Ritzcon Biological Technology Co., Ltd., Shenzhen, People's Republic of China.,School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong, People's Republic of China
| | - Fuling Zhong
- Shenzhen Blood Centre, Shenzhen Institute of Transfusion Medicine, Shenzhen, People's Republic of China
| | - Wenxu Hong
- Shenzhen Blood Centre, Shenzhen Institute of Transfusion Medicine, Shenzhen, People's Republic of China
| | - Yuqing Su
- Shenzhen Blood Centre, Shenzhen Institute of Transfusion Medicine, Shenzhen, People's Republic of China
| | - Fan Wu
- Shenzhen Blood Centre, Shenzhen Institute of Transfusion Medicine, Shenzhen, People's Republic of China
| | - Shuang Liang
- Shenzhen Blood Centre, Shenzhen Institute of Transfusion Medicine, Shenzhen, People's Republic of China
| | - Jun Liu
- R&D Division, Shenzhen Ritzcon Biological Technology Co., Ltd., Shenzhen, People's Republic of China
| | - Shuanghua Fang
- R&D Division, Shenzhen Ritzcon Biological Technology Co., Ltd., Shenzhen, People's Republic of China
| | - Yanwen Liang
- R&D Division, Shenzhen Ritzcon Biological Technology Co., Ltd., Shenzhen, People's Republic of China
| | - Xiuchu Fan
- R&D Division, Shenzhen Ritzcon Biological Technology Co., Ltd., Shenzhen, People's Republic of China
| | - Jiansuo Lin
- R&D Division, Shenzhen Ritzcon Biological Technology Co., Ltd., Shenzhen, People's Republic of China
| | - Yi Liu
- Guangdong Key Laboratory for Research and Development of Natural Drugs, Department of Pharmacology, Marine Medicine Research Institute, Guangdong Medical University, Zhanjiang, People's Republic of China
| | - Bo Feng
- School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong, People's Republic of China
| | - Yunping Xu
- Shenzhen Blood Centre, Shenzhen Institute of Transfusion Medicine, Shenzhen, People's Republic of China
| |
Collapse
|
2
|
Wei L, Sun A, Wen J, Wang Z, Li Q, Liao Y, Luo G, Ji Y. Molecular genetic analysis of Mi a -positive hybrid glycophorins revealed two novel alleles of GP.Vw and multiple variant transcripts of GYPB existing in both the homozygous GP.Mur and wild-type GPB individuals. Transfusion 2021; 61:2477-2486. [PMID: 34117642 DOI: 10.1111/trf.16450] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/18/2020] [Revised: 03/16/2021] [Accepted: 04/28/2021] [Indexed: 11/29/2022]
Abstract
BACKGROUND The hybrid glycophorins of MNS blood group system express a series of low incidence antigens including Mia , which are commonly found in Southeast Asian populations. In this study, the molecular basis of Mia -positive hybrid glycophorins was firstly clarified in the Chinese Southern Han population. RNA transcripts of GYPB gene in the homozygous GP.Mur individuals were also analyzed. STUDY DESIGN AND METHODS DNAs were extracted from the whole blood samples of 111 Mia -positive donors. Then, high-resolution melting (HRM) analysis for GYP(B-A-B) was used to analyze the genotypes. Sequencing of GYPB pseudoexon 3 was conducted in the samples with variant melting curves. TA-cloning and subsequent sequencing of GYPA exons 2-4 were performed in the Mia -positive samples with normal GYPB/GYPB genotype by HRM. The transcript analysis of GYPB was conducted in homozygous GP.Mur and wild-type glycophorin B (GPB) individuals using RNA extracted from the cultured erythroblast. RESULTS The heterozygous GYP*Mur/GYPB (n = 101), homozygous GYP*Mur/GYP*Mur (n = 7) including one novel GYP*Mur allele with an extra GYPA/GYPE specific nucleotide substitution (c.229+110A>T), heterozygous GYP*Bun/GYPB (n = 1) and GYP*Vw/GYPA (n = 2) with two novel GYP*Vw alleles were identified. RNA transcript analysis revealed multiple transcripts of GYPB existing in both homozygous GP.Mur and normal GPB individuals. CONCLUSION The results showed the genetic diversity of hybrid glycophorins in the Chinese population. Besides, the successful analysis of GYPB transcripts indicates that the cultured erythroblast is a good source for RNA transcript analysis for the protein only expressed on the red blood cells.
Collapse
Affiliation(s)
- Ling Wei
- Institute of Clinical Blood Transfusion, Guangzhou Blood Center, Guangzhou, People's Republic of China
| | - Ainong Sun
- Department of Laboratory Medicine, Zhongshan Blood Center, Zhongshan, People's Republic of China
| | - Jizhi Wen
- Institute of Clinical Blood Transfusion, Guangzhou Blood Center, Guangzhou, People's Republic of China
| | - Zhen Wang
- Institute of Clinical Blood Transfusion, Guangzhou Blood Center, Guangzhou, People's Republic of China
| | - Qiao Li
- Department of Laboratory Medicine, Zhongshan Blood Center, Zhongshan, People's Republic of China
| | - Yanting Liao
- Department of Laboratory Medicine, Zhongshan Blood Center, Zhongshan, People's Republic of China
| | - Guangping Luo
- Institute of Clinical Blood Transfusion, Guangzhou Blood Center, Guangzhou, People's Republic of China
| | - Yanli Ji
- Institute of Clinical Blood Transfusion, Guangzhou Blood Center, Guangzhou, People's Republic of China
| |
Collapse
|
3
|
Amuzu DS, Rockett KA, Leffler EM, Ansah F, Amoako N, Morang'a CM, Hubbart C, Rowlands K, Jeffreys AE, Amenga-Etego LN, Kwiatkowski DP, Awandare GA. High-throughput genotyping assays for identification of glycophorin B deletion variants in population studies. Exp Biol Med (Maywood) 2020; 246:916-928. [PMID: 33325748 PMCID: PMC8022085 DOI: 10.1177/1535370220968545] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
Glycophorins are the most abundant sialoglycoproteins on the surface of human erythrocyte membranes. Genetic variation in glycophorin region of human chromosome 4 (containing GYPA, GYPB, and GYPE genes) is of interest because the gene products serve as receptors for pathogens of major public health interest, including Plasmodiumsp., Babesiasp., Influenza virus, Vibrio cholerae El Tor Hemolysin, and Escherichia coli. A large structural rearrangement and hybrid glycophorin variant, known as Dantu, which was identified in East African populations, has been linked with a 40% reduction in risk for severe malaria. Apart from Dantu, other large structural variants exist, with the most common being deletion of the whole GYPB gene and its surrounding region, resulting in multiple different deletion forms. In West Africa particularly, these deletions are estimated to account for between 5 and 15% of the variation in different populations, mostly attributed to the forms known as DEL1 and DEL2. Due to the lack of specific variant assays, little is known of the distribution of these variants. Here, we report a modification of a previous GYPB DEL1 assay and the development of a novel GYPB DEL2 assay as high-throughput PCR-RFLP assays, as well as the identification of the crossover/breakpoint for GYPB DEL2. Using 393 samples from three study sites in Ghana as well as samples from HapMap and 1000 G projects for validation, we show that our assays are sensitive and reliable for genotyping GYPB DEL1 and DEL2. To the best of our knowledge, this is the first report of such high-throughput genotyping assays by PCR-RFLP for identifying specific GYPB deletion types in populations. These assays will enable better identification of GYPB deletions for large genetic association studies and functional experiments to understand the role of this gene cluster region in susceptibility to malaria and other diseases.
Collapse
Affiliation(s)
- Dominic Sy Amuzu
- West African Centre for Cell Biology of Infectious Pathogens, University of Ghana, Accra, GH 0233, Ghana.,Department of Biochemistry, Cell and Molecular Biology, University of Ghana, Accra, GH 0233, Ghana.,Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, UK
| | - Kirk A Rockett
- Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, UK.,Wellcome Sanger Institute, Hinxton CB10 1SA, UK
| | - Ellen M Leffler
- Wellcome Sanger Institute, Hinxton CB10 1SA, UK.,Department of Human Genetics, Eccles Institute of Human Genetics, University of Utah, Salt Lake City, UT 84112-5330, USA
| | - Felix Ansah
- West African Centre for Cell Biology of Infectious Pathogens, University of Ghana, Accra, GH 0233, Ghana.,Department of Biochemistry, Cell and Molecular Biology, University of Ghana, Accra, GH 0233, Ghana
| | - Nicholas Amoako
- West African Centre for Cell Biology of Infectious Pathogens, University of Ghana, Accra, GH 0233, Ghana.,Department of Biochemistry, Cell and Molecular Biology, University of Ghana, Accra, GH 0233, Ghana
| | - Collins M Morang'a
- West African Centre for Cell Biology of Infectious Pathogens, University of Ghana, Accra, GH 0233, Ghana.,Department of Biochemistry, Cell and Molecular Biology, University of Ghana, Accra, GH 0233, Ghana
| | - Christina Hubbart
- Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, UK
| | - Kate Rowlands
- Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, UK
| | - Anna E Jeffreys
- Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, UK
| | - Lucas N Amenga-Etego
- West African Centre for Cell Biology of Infectious Pathogens, University of Ghana, Accra, GH 0233, Ghana.,Department of Biochemistry, Cell and Molecular Biology, University of Ghana, Accra, GH 0233, Ghana
| | - Dominic P Kwiatkowski
- Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, UK.,Wellcome Sanger Institute, Hinxton CB10 1SA, UK.,Big Data Institute, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, UK
| | - Gordon A Awandare
- West African Centre for Cell Biology of Infectious Pathogens, University of Ghana, Accra, GH 0233, Ghana.,Department of Biochemistry, Cell and Molecular Biology, University of Ghana, Accra, GH 0233, Ghana
| |
Collapse
|
4
|
Gholamrezazade A, Amirizadeh N, Oodi A. Genotyping analysis of the MNS blood group system of thalassemia patients with alloantibodies in Iran. Transfus Apher Sci 2020; 60:103006. [PMID: 33229298 DOI: 10.1016/j.transci.2020.103006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/23/2020] [Revised: 10/27/2020] [Accepted: 10/29/2020] [Indexed: 10/23/2022]
Abstract
BACKGROUND Serological methods are unreliable for accurate determination of blood group antigens in multi-transfused thalassemia patients. The MNS blood group system has five high-frequency antigens. Many studies demonstrated that some antibodies including anti-S, anti-s, and anti-U may cause acute and delayed transfusion reactions and hemolytic disease of the fetus and newborn. This study aimed to determine the genotype of the MNS blood group in thalassemia patients with alloantibodies by molecular methods. MATERIAL AND METHODS In this study, 104 blood samples from thalassemia patients were collected. The blood group phenotype for M, N, S and s antigens was determined by the tube hemagglutination method. MNS blood group genotyping was performed using PCR-SSP and DNA Sequencing methods. RESULTS All patients were genotyped with a total of 6 pairs of primers. Discrepancies between genotype and phenotype were observed in 22 patients with S/s alleles and 2 patients with M/N alleles, however, there was full accordance between the results of SSP-PCR and DNA sequencing. The frequency of MNS blood group alleles was determined as follows: 25 % MNSs, 23 % MNss, 21 % MMSs, 9% MMSS, 9% MMss, 8% NNss, 2%MNSS, and NNSS, NNSs, MM genotypes at 1% each. CONCLUSION In conclusion, molecular genotyping is more reliable than serological methods in multiple transfusion patients and can lead to a more compatible blood unit for transfusion in these patients.
Collapse
Affiliation(s)
- Atefe Gholamrezazade
- Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran.
| | - Naser Amirizadeh
- Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran.
| | - Arezoo Oodi
- Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran.
| |
Collapse
|
5
|
Polin H, Pelc-Klopotowska M, Danzer M, Suessner S, Gabriel C, Wilflingseder J, Żmudzin A, Orzińska A, Guz K, Michalewska B, Brojer E. Compound heterozygosity of two novelRHAGalleles leads to a considerable disruption of the Rh complex. Transfusion 2016; 56:950-5. [DOI: 10.1111/trf.13476] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/09/2015] [Revised: 10/13/2015] [Accepted: 11/19/2015] [Indexed: 01/14/2023]
Affiliation(s)
- Helene Polin
- Red Cross Transfusion Service of Upper Austria; Linz Austria
- Ludwig Boltzmann Institute for Experimental and Clinical Traumatology; Linz Austria
| | | | - Martin Danzer
- Red Cross Transfusion Service of Upper Austria; Linz Austria
- Ludwig Boltzmann Institute for Experimental and Clinical Traumatology; Linz Austria
| | - Susanne Suessner
- Red Cross Transfusion Service of Upper Austria; Linz Austria
- Ludwig Boltzmann Institute for Experimental and Clinical Traumatology; Linz Austria
| | - Christian Gabriel
- Red Cross Transfusion Service of Upper Austria; Linz Austria
- Ludwig Boltzmann Institute for Experimental and Clinical Traumatology; Linz Austria
| | | | | | | | - Katarzyna Guz
- Institute of Hematology and Transfusion Medicine; Warsaw Poland
| | | | - Ewa Brojer
- Institute of Hematology and Transfusion Medicine; Warsaw Poland
| |
Collapse
|